Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Tattelecom reported for 9 months of 2023 by RAS

11/10/23 TTLK

Rostelecom will present a new strategy and div policy in Q2 2024

11/9/23 RTKM

Fix Price moves to Kazakhstan

11/9/23 FIXP

Board of Directors of Gazprom Neft recommended that dividends be paid for 9 months 2023

11/9/23 SIBN

PhosAgro sales for 9 months of 2023 increased by 2.5%

11/9/23 PHOR

PhosAgro reports for 9 months of 2023 by IFRS

11/9/23 PHOR

Board of Directors of Phosagro recommended dividends

11/9/23 PHOR

Cosmos Hotel Group will open the first five-star hotel in Dombai resort

11/9/23 AFKS

Rosatom's task is to manage maritime traffic on the Northern Sea Route

11/9/23 FESH

Yakovlev to place additional share issue at ₽21.8 per share

11/9/23 IRKT